Healthpeak Properties (NYSE:DOC) Hits New 52-Week High – Should You Buy?

Shares of Healthpeak Properties, Inc. (NYSE:DOC) reached a new 52-week high during trading on Tuesday . The stock traded as high as $19.98 and last traded at $19.95, with a volume of 3153911 shares traded. The stock had previously closed at $19.73.

Wall Street Analyst Weigh In

DOC has been the subject of several recent analyst reports. Citigroup raised their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. UBS Group upped their price objective on Healthpeak Properties from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, May 13th. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Morgan Stanley upped their price objective on Healthpeak Properties from $18.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 22nd. Finally, Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Five research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $19.23.

Healthpeak Properties Price Performance

The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The company’s 50 day moving average is $17.70 and its 200 day moving average is $17.32. The stock has a market cap of $13.44 billion, a price-to-earnings ratio of 60.90, a PEG ratio of 2.52 and a beta of 1.00.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. During the same quarter last year, the business earned $0.46 earnings per share. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be paid a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 6.3%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Insider Activity at Healthpeak Properties

In related news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares in the company, valued at $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.23% of the stock is owned by company insiders.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds have recently added to or reduced their stakes in DOC. Norges Bank purchased a new position in Healthpeak Properties during the 4th quarter valued at about $153,550,000. JPMorgan Chase & Co. increased its holdings in Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after acquiring an additional 8,212,504 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after acquiring an additional 7,007,777 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in Healthpeak Properties by 60.3% during the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after acquiring an additional 5,815,189 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its holdings in Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after acquiring an additional 4,776,056 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.